EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol

PHASE4CompletedINTERVENTIONAL
Enrollment

970

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Venous ThromboembolismAtrial Fibrillation
Interventions
OTHER

Genotype-guided dosing algorithm

Loading and monitoring dose according to genotype-guided dosing algorithm

OTHER

Non-genotype-guided dosing algorithm

Loading and monitoring dose according to non-genotype-guided dosing algorithm

Trial Locations (2)

Unknown

Democritus University of Thrace Medical School, Alexandropoulis

Utrecht University, Utrecht

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Utrecht University

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

University of Ulm

OTHER

collaborator

Newcastle University

OTHER

collaborator

University of Liverpool

OTHER

collaborator

LGC Limited

INDUSTRY

collaborator

Uppsala University

OTHER

collaborator

Democritus University of Thrace

OTHER

collaborator

Elisabethinen Hospital

OTHER

lead

Utrecht Institute for Pharmaceutical Sciences

OTHER